APRI as a predictor of early viral response in chronic hepatitis C patients

Table 2 Clinical characteristics in EVR and non-EVR patients (n = 80)

Variable	EVR patients (n = 54)	Non-EVR patients (n = 26)	P value
Age (yr)	43.61 ± 11.92	41.65 ± 12.90	0.505
Weight (kg)	71.09 ± 11.77	68.69 ± 9.88	0.372
WBC (cells/mm3)	5,824 ± 1.901	5.040 ± 1.850	0.820
Hemoglobin (g/dL)	14.86 ± 2.05	14.77 ± 1.74	0.855
Platelets (No/μL)	212,162 ± 79.956	207 815 ± 94 603	0.781
Glucose (mg/dL)	101.16 ± 18.94	99.96 ± 17.13	0.697
Creatinine (mg/dL)	0.97 ± 0.31	0.93 ± 0.11	0.552
AST (IU/mL)	62.07 ± 46.52	69.84 ± 53.64	0.508
ALT (IU/mL)	72.81 ± 62.15	83.61 ± 65.62	0.477
LDH (IU/mL)	276.96 ± 99.77	263.65 ± 70.12	0.543
HCV RNA viral load (copies/mL)	2 243 191 ± 7 664 170	2 322 791 ± 6 263 297	0.964
APRI	1.47 ± 1.63	1.90 ± 2.37	0.353

EVR: Early viral response; HCV: Hepatitis C virus.